rs876657790
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The ENST00000261590.13(DSG2):āc.308T>Cā(p.Val103Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
ENST00000261590.13 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSG2 | NM_001943.5 | c.308T>C | p.Val103Ala | missense_variant | 4/15 | ENST00000261590.13 | NP_001934.2 | |
DSG2 | XM_047437315.1 | c.-227T>C | 5_prime_UTR_variant | 5/16 | XP_047293271.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSG2 | ENST00000261590.13 | c.308T>C | p.Val103Ala | missense_variant | 4/15 | 1 | NM_001943.5 | ENSP00000261590 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249158Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135200
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461612Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727102
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 27, 2017 | The p.Val103Ala variant in DSG2 has been identified by our laboratory in one ind ividual with DCM and segregated with disease in one affected relative. Both of t hese individuals also carried a likely pathogenic variant in a different gene su fficient to cause disease. The p.Val103Ala has not been previously reported in t he literature and is absent from large population studies. Valine (Val) at posit ion 103 is not conserved in mammals or evolutionarily distant species and 1 mamm al (big brown bat) carries an alanine (Ala), raising the possibility that this c hange may be tolerated. Additional computational prediction tools do not provide strong support for or against an impact to the protein. In summary, the clinica l significance of the p.Val103Ala variant is uncertain. - |
Arrhythmogenic right ventricular cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Dec 01, 2023 | This missense variant replaces valine with alanine at codon 103 of the DSG2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in at least one individual affected with dilated cardiomyopathy (PMID: 31983221; ClinVar: SCV000271711.2) and in one individual with Diamond-Blackfan anemia type 1 with sinus bradycardia who also carried a pathogenic variant in the RPS19 gene (PMID: 36837563). This variant has been identified in 1/249158 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Oct 10, 2023 | This missense variant replaces valine with alanine at codon 103 of the DSG2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in at least one individual affected with dilated cardiomyopathy (PMID: 31983221; ClinVar: SCV000271711.2) and in one individual with Diamond-Blackfan anemia type 1 with sinus bradycardia who also carried a pathogenic variant in the RPS19 gene (PMID: 36837563). This variant has been identified in 1/249158 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Arrhythmogenic right ventricular dysplasia 10 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 08, 2022 | This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 103 of the DSG2 protein (p.Val103Ala). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DSG2 protein function. ClinVar contains an entry for this variant (Variation ID: 228627). This variant has not been reported in the literature in individuals affected with DSG2-related conditions. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 26, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Reported in an individual with sinus bradycardia and Diamond-Blackfan anemia who also harbored a de novo variant in the RPS19 gene (PMID: 36837563); This variant is associated with the following publications: (PMID: 36837563) - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2015 | The p.V103A variant (also known as c.308T>C), located in coding exon 4 of the DSG2 gene, results from a T to C substitution at nucleotide position 308. The valine at codon 103 is replaced by alanine, an amino acid with similar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 5872 samples (11744 alleles) with coverage at this position. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at